TY - JOUR
T1 - Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers
AU - Moss, Tyler J.
AU - Luo, Zijun
AU - Seviour, Elena G.
AU - Sehgal, Vasudha
AU - Lu, Yiling
AU - Hill, Steven M.
AU - Rupaimoole, Rajesha
AU - Lee, Ju Seog
AU - Rodriguez-Aguayo, Cristian
AU - Lopez-Berestein, Gabriel
AU - Sood, Anil K.
AU - Azencott, Robert
AU - Gray, Joe W.
AU - Mukherjee, Sach
AU - Mills, Gordon B.
AU - Ram, Prahlad T.
N1 - Funding Information:
This work was supported by the National Institutes of Health, National Cancer Institute grant U54 CA 112970 and the Blanton-Davis Ovarian Cancer Foundation. TJM was supported by the Odyssey Foundation MDACC and the NLM Biomedical Informatics Training Program, VS was supported by the CPRIT Computational Cancer Biology Training Program. Supported by the NIH/NCI under award number P50 CA112970, U54 CA151668, RP110595.
Publisher Copyright:
© 2015 The Systems Biology Institute/Macmillan Publishers Limited.
PY - 2015/9/28
Y1 - 2015/9/28
N2 - BACKGROUND: Regulation of gene expression by microRNAs (miRNAs) is critical for determining cellular fate and function. Dysregulation of miRNA expression contributes to the development and progression of multiple diseases. miRNA can target multiple mRNAs, making deconvolution of the effects of miRNA challenging and the complexity of regulation of cellular pathways by miRNAs at the functional protein level remains to be elucidated. Therefore, we sought to determine the effects of expression of miRNAs in breast and ovarian cancer cells on cellular pathways by measuring systems-wide miRNA perturbations to protein and phosphoproteins. METHODS: We measure protein level changes by reverse-phase protein array (RPPA) in MDA-MB-231, SKOV3.ip1 and HEYA8 cancer cell lines transfected by a library of 879 human miRNA mimics. RESULTS: The effects of multiple miRNAs-protein networks converged in five broad functional clusters of miRNA, suggesting a broad overlap of miRNA action on cellular pathways. Detailed analysis of miRNA clusters revealed novel miRNA/cell cycle protein networks, which we functionally validated. De novo phosphoprotein network estimation using Gaussian graphical modeling, using no priors, revealed known and novel protein interplay, which we also observed in patient ovarian tumor proteomic data. We identified several miRNAs that have pluripotent activities across multiple cellular pathways. In particular we studied miR-365a whose expression is associated with poor survival across several cancer types and demonstrated that anti-miR-365 significantly reduced tumor formation in animal models. CONCLUSIONS: Mapping of miRNA-induced protein and phosphoprotein changes onto pathways revealed new miRNA-cellular pathway connectivity, paving the way for targeting of dysregulated pathways with potential miRNA-based therapeutics.
AB - BACKGROUND: Regulation of gene expression by microRNAs (miRNAs) is critical for determining cellular fate and function. Dysregulation of miRNA expression contributes to the development and progression of multiple diseases. miRNA can target multiple mRNAs, making deconvolution of the effects of miRNA challenging and the complexity of regulation of cellular pathways by miRNAs at the functional protein level remains to be elucidated. Therefore, we sought to determine the effects of expression of miRNAs in breast and ovarian cancer cells on cellular pathways by measuring systems-wide miRNA perturbations to protein and phosphoproteins. METHODS: We measure protein level changes by reverse-phase protein array (RPPA) in MDA-MB-231, SKOV3.ip1 and HEYA8 cancer cell lines transfected by a library of 879 human miRNA mimics. RESULTS: The effects of multiple miRNAs-protein networks converged in five broad functional clusters of miRNA, suggesting a broad overlap of miRNA action on cellular pathways. Detailed analysis of miRNA clusters revealed novel miRNA/cell cycle protein networks, which we functionally validated. De novo phosphoprotein network estimation using Gaussian graphical modeling, using no priors, revealed known and novel protein interplay, which we also observed in patient ovarian tumor proteomic data. We identified several miRNAs that have pluripotent activities across multiple cellular pathways. In particular we studied miR-365a whose expression is associated with poor survival across several cancer types and demonstrated that anti-miR-365 significantly reduced tumor formation in animal models. CONCLUSIONS: Mapping of miRNA-induced protein and phosphoprotein changes onto pathways revealed new miRNA-cellular pathway connectivity, paving the way for targeting of dysregulated pathways with potential miRNA-based therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=85028256122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028256122&partnerID=8YFLogxK
U2 - 10.1038/npjsba.2015.1
DO - 10.1038/npjsba.2015.1
M3 - Article
AN - SCOPUS:85028256122
SN - 2056-7189
VL - 1
JO - npj Systems Biology and Applications
JF - npj Systems Biology and Applications
M1 - 15001
ER -